Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▲ +1.4% | ▼ −1.7% | ▼ −0.7% | ▲ +16.5% | ▲ +17.5% | ▲ +49.1% | — | ▲ +25.8% |
| Peer average | — | — | — | — | — | — | — | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
The Simplify Propel Opportunities ETF (SURI) aims to deliver substantial long-term capital growth. It achieves this by investing in companies across the biotechnology, pharmaceutical, healthcare technology, and life sciences industries. These particular firms are selected because they are believed to be overlooked by investors, suggesting significant potential for their value to increase. Propel, the fund's sub-advisor, applies its deep scientific and commercial knowledge in health sciences to identify and select the most promising investment opportunities within this sector.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2026-09-25 | 2026-09-30 | $0.68 |
| 2026-06-25 | 2026-06-30 | $0.68 |
| 2026-03-26 | 2026-03-31 | $0.68 |
| 2025-12-23 | 2025-12-31 | $0.68 |
| 2025-09-25 | 2025-09-30 | $0.68 |
| 2025-06-25 | 2025-06-30 | $0.68 |
| 2025-03-26 | 2025-03-31 | $0.68 |
| 2024-12-23 | 2024-12-31 | $0.68 |
| 2024-09-25 | 2024-09-30 | $0.68 |
| 2024-06-25 | 2024-06-28 | $1.25 |
| 2024-03-25 | 2024-03-28 | $0.68 |
| 2023-12-26 | 2023-12-29 | $0.68 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind SURI.